CYP19A1 and rheumatoid arthritis: The inadequate response to LEF in RA might be attributed to elevated methylation levels influencing aromatase activity (a metric indicative of the amount of PON1 protein in the bloodstream) (Huen et al., 2015; Diels et al., 2021; de la Iglesia et al., 2014).